Cargando…

First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion

Poly(ADP-ribose) polymerase (PARP) inhibitor maintenance therapy is the latest breakthrough in the management of newly diagnosed advanced ovarian cancer. The results of the SOLO-1 trial in 2018 led to European Medicines Agency and Food and Drug Administration approval of olaparib as first-line maint...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banerjee, Susana, Gonzalez-Martin, Antonio, Harter, Philipp, Lorusso, Domenica, Moore, Kathleen N, Oaknin, Ana, Ray-Coquard, Isabelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783599/ https://www.ncbi.nlm.nih.gov/pubmed/33310779 http://dx.doi.org/10.1136/esmoopen-2020-001110

Ejemplares similares

Introducing pro and con discussions in ESMO Open—Cancer Horizons
por: Zielinski, C., et al.
Publicado: (2022)

Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion
por: Burke, Patrick W, et al.
Publicado: (2020)

CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open—Cancer Horizons pro and con discussion
por: Awada, Ahmad, et al.
Publicado: (2019)

Round table discussion
por: CERN. Geneva
Publicado: (2021)

CSCO joins ESMO Open—Cancer Horizons
por: Zielinski, Christoph C, et al.
Publicado: (2016)

ESMO Open—Cancer Horizons and the future of oncology
por: Zielinski, Christoph C
Publicado: (2016)

Discussion and Round Table Presentation
Publicado: (1991)

Summary of the ACAT Round Table Discussion: Open-source, knowledge sharing and scientific collaboration
por: Carminati, Federico, et al.
Publicado: (2014)

Future facilities: round table discussion
por: Scheck, F, et al.
Publicado: (1989)

Round table discussion on direct photons
por: Aurenche, Patrick, et al.
Publicado: (1988)

CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussion
por: Preusser, Matthias, et al.
Publicado: (2018)

Correction: CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussion
Publicado: (2019)

Informal round table discussion on slow ejection
por: Reich, K H
Publicado: (1963)

Round Table: Discussion with families and lay associations
por: Mongini, Tiziana, et al.
Publicado: (2015)

AIOM chooses ESMO Open—Cancer Horizons as its official journal: a warm welcome from ESMO Open
por: Zielinski, Christoph C, et al.
Publicado: (2016)

NUFACT11 round table discussion: questions and answers
por: Blondel, A, et al.
Publicado: (2013)

One year of ESMO Open: Cancer Horizons—where are we going from here?
por: Zielinski, Christoph
Publicado: (2017)

Role of Biopersistence in the Pathogenicity of Man-made Fibers and Methods for Evaluating Biopersistence: A Summary of Two Round-table Discussions
por: McClellan, Roger O., et al.
Publicado: (1994)

Summary of World Café Discussions Table 3: Dissemination
por: Ziese, Thomas, et al.
Publicado: (2020)

Summary of World Café Discussions Table 2: Evaluation
por: Haller, Sebastian, et al.
Publicado: (2020)

Summary of World Café Discussions Table 1: Assessment
por: Fehr, Angela, et al.
Publicado: (2020)

Immune checkpoint inhibitor treatment in patients with oncogene-addicted non-small cell lung cancer (NSCLC): summary of a multidisciplinary round-table discussion
por: Berghoff, Anna S., et al.
Publicado: (2019)

Round-table discussion on Hadron colliders versus e+e- colliders
por: Cabibbo, Nicola
Publicado: (1983)

OncoAlert Round Table Discussions: The Global COVID-19 Experience
por: Morgan, Gilberto, et al.
Publicado: (2021)

Commentary on: Round Table Discussion: Making Sense of Current Liposuction Technologies
por: Aly, Al
Publicado: (2022)

round table
por: Sloan, Terry, et al.
Publicado: (2019)

Round table
por: Hoffmann, Hans Falk
Publicado: (2004)

Round Table
por: CERN. Geneva
Publicado: (2021)

Integration of PARP-inhibitors in ovarian cancer therapy
por: Pietragalla, Antonella, et al.
Publicado: (2020)

PARP Inhibitors: A New Horizon for Patients with Prostate Cancer
por: Congregado, Belén, et al.
Publicado: (2022)

Challenges and future direction of online and blended education: a note on the round table discussion
por: Chakrabarty, Manisha
Publicado: (2022)

Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon?
por: Musacchio, L., et al.
Publicado: (2022)

Overcoming resistance to PARP inhibitor in epithelial ovarian cancer, are we ready?
por: Ray-Coquard, Isabelle, et al.
Publicado: (2020)

Round the table at Vienna
Publicado: (1968)

The round table : Characters of Shakespear's plays
por: Hazlitt, William, 1778-1830
Publicado: (1957)

ESMO 2021—highlights in colorectal cancer
por: Weiss, Lukas
Publicado: (2022)

ESMO 2020: highlights in breast cancer
por: Bartsch, Rupert
Publicado: (2021)

Qualitative Analysis of Round-Table Discussions on the Business Case and Procurement Challenges for Hospital Electronic Prescribing Systems
por: Cresswell, Kathrin M., et al.
Publicado: (2013)

Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group
por: Thriemer, Kamala, et al.
Publicado: (2018)

Round Table on Quantum Computing
por: Carminati, Federico
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7eoekebktnojefhe8hud73no2d